Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 2/20 | 0.36 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.31 |
| ▸ | MAPT | P10636 | 3/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7547391 | 0.95 | MAPT (0.33) | MTNR1AMTNR1BMAPTL3MBTL1TDP1 | |
| SCHEMBL7555174 | 0.87 | MTNR1A (0.34) | MTNR1AMTNR1BLMNAKDM4EHSD17B10 | |
| SCHEMBL7550093 | 0.87 | PPARD (0.33) | MAPTL3MBTL1TDP1 | |
| SCHEMBL7549043 | 0.87 | MTNR1A (0.33) | MTNR1AMTNR1BLMNAKDM4EMAPT | |
| SCHEMBL7547267 | 0.86 | MTNR1A (0.32) | MTNR1AMTNR1BMAPTL3MBTL1TDP1 | |
| SCHEMBL7548639 | 0.86 | MTNR1A (0.32) | MTNR1AMTNR1BKDM4EL3MBTL1CACNA1B | |
| SCHEMBL7550462 | 0.84 | MTNR1A (0.32) | MTNR1AMTNR1BL3MBTL1 | |
| SCHEMBL7551094 | 0.82 | MTNR1A (0.34) | MTNR1AMTNR1BLMNAKDM4EALDH1A1 | |
| SCHEMBL7554385 | 0.82 | GLS (0.30) | MTNR1AMTNR1B | |
| SCHEMBL7653673 | 0.81 | ROCK2 (0.31) | MAPTNPSR1L3MBTL1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0657427-B1 | Tricyclic indole-2-carboxylic acid derivatives being selective antagonists of the NMDA receptor | SUMITOMO PHARMA (JP) | 2002-06-19 | — | — | EP | disclosed |
| US-5496843-A | Tricyclic indole-2-carboxylic acid derivatives | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 1996-03-05 | — | — | US | disclosed |
| EP-0657427-A1 | Tricyclic indole-2-carboxylic acid derivatives being selective antagonists of the NMDA receptor | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 1995-06-14 | — | — | EP | disclosed |